Effects of rapid recruitment and dissemination on Covid-19 mortality: the RECOVERY trial [version 2; peer review: 2 approved]
The RECOVERY trial is a large multi-armed, adaptive randomised controlled trial of treatments for Covid-19. It has rapidly recruited and demonstrated that hydroxychloroquine is ineffective in reducing mortality for hospitalised patients, whilst dexamethasone significantly reduces mortality among th...
Main Authors: | Catherine Knowlson, David J. Torgerson |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2020-12-01
|
Series: | F1000Research |
Online Access: | https://f1000research.com/articles/9-1017/v2 |
Similar Items
-
Using pens as an incentive for trial recruitment of older adults: An embedded randomised controlled trial [version 1; peer review: 2 approved]
by: Katie Whiteside, et al.
Published: (2019-03-01) -
Participants’ perspectives and preferences on clinical trial result dissemination: The TRUST Thyroid Trial experience [version 2; peer review: 2 approved]
by: Emmy Racine, et al.
Published: (2019-03-01) -
COVID-19 in-patient hospital mortality by ethnicity [version 1; peer review: 2 approved]
by: Gillian Santorelli, et al.
Published: (2020-05-01) -
Participants’ perspectives and preferences on clinical trial result dissemination: The TRUST Thyroid Trial experience [version 1; peer review: 2 approved]
by: Emmy Racine, et al.
Published: (2018-04-01) -
Postal recruitment for genetic studies of preterm birth: A feasibility study [version 2; peer review: 2 approved, 2 not approved]
by: Oonagh E. Keag, et al.
Published: (2020-06-01)